87 related articles for article (PubMed ID: 3002612)
1. Secretin/vasoactive intestinal peptide-stimulated secretion of bombesin/gastrin releasing peptide from human small cell carcinoma of the lung.
Korman LY; Carney DN; Citron ML; Moody TW
Cancer Res; 1986 Mar; 46(3):1214-8. PubMed ID: 3002612
[TBL] [Abstract][Full Text] [Related]
2. Vasoactive intestinal peptide (VIP) stimulates in vitro growth of VIP-1 receptor-bearing human pancreatic adenocarcinoma-derived cells.
Jiang S; Kopras E; McMichael M; Bell RH; Ulrich CD
Cancer Res; 1997 Apr; 57(8):1475-80. PubMed ID: 9108448
[TBL] [Abstract][Full Text] [Related]
3. The release of bombesin-like peptides from small cell lung cancer cells.
Moody TW; Korman LY
Ann N Y Acad Sci; 1988; 547():351-9. PubMed ID: 2853597
[TBL] [Abstract][Full Text] [Related]
4. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
Zawilska JB; Niewiadomski P; Nowak JZ
Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130
[TBL] [Abstract][Full Text] [Related]
5. Effects of vasoactive intestinal peptide and secretin on gastrin and somatostatin secretion in the perfused rat stomach.
Saffouri B; DuVal JW; Arimura A; Makhlouf GM
Gastroenterology; 1984 May; 86(5 Pt 1):839-42. PubMed ID: 6142844
[TBL] [Abstract][Full Text] [Related]
6. Gastrin-releasing peptide directly releases pepsinogen from guinea pig chief cells.
Fiorucci S; McArthur KE
Am J Physiol; 1990 Nov; 259(5 Pt 1):G760-6. PubMed ID: 1700625
[TBL] [Abstract][Full Text] [Related]
7. Effect of vasoactive intestinal peptide, peptide histidine isoleucine and growth hormone-releasing factor-40 on bombesin-like immunoreactivity, somatostatin and gastrin release from the perfused rat stomach.
Schusdziarra V; Schmid R; Bender H; Schusdziarra M; Rivier J; Vale W; Classen M
Peptides; 1986; 7(1):127-33. PubMed ID: 2872659
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic secretion and cyclic AMP in pancreatic tissue after intravenous infusion of secretin and vasoactive intestinal peptide in cats.
Mikoś E; Mitis-Musioł M; Radecki T; Konturek S
Acta Physiol Pol; 1980; 31(1):53-9. PubMed ID: 6246717
[TBL] [Abstract][Full Text] [Related]
9. BN/GRP-like peptides and receptors in small cell lung cancer.
Moody TW; Lebovic GS; Carney DN; Korman LY
Int J Neurosci; 1988 May; 40(1-2):141-8. PubMed ID: 2840406
[TBL] [Abstract][Full Text] [Related]
10. Nonconstitutive expression of the gastrin-releasing peptide autocrine growth system in human small cell lung carcinoma NCI-H345 cells.
Aguayo SM; Miller Y; Boose D; Holley M; Portanova LB; Schuyler KD; Kane MA
Cell Growth Differ; 1996 May; 7(5):563-72. PubMed ID: 8732666
[TBL] [Abstract][Full Text] [Related]
11. Targeted cytotoxic analogue of bombesin/gastrin-releasing peptide inhibits the growth of H-69 human small-cell lung carcinoma in nude mice.
Kiaris H; Schally AV; Nagy A; Sun B; Armatis P; Szepeshazi K
Br J Cancer; 1999 Nov; 81(6):966-71. PubMed ID: 10576652
[TBL] [Abstract][Full Text] [Related]
12. An immunoconjugate of Lys3-bombesin and monoclonal antibody 22 can specifically induce FcgammaRI (CD64)-dependent monocyte- and neutrophil-mediated lysis of small cell carcinoma of the lung cells.
Chen J; Mokotoff M; Zhou JH; Fanger MW; Ball ED
Clin Cancer Res; 1995 Apr; 1(4):425-34. PubMed ID: 9816000
[TBL] [Abstract][Full Text] [Related]
13. Newly-identified receptors for peptide histidine-isoleucine and GHRH-like peptide in zebrafish help to elucidate the mammalian secretin superfamily.
Wu S; Roch GJ; Cervini LA; Rivier JE; Sherwood NM
J Mol Endocrinol; 2008 Nov; 41(5):343-66. PubMed ID: 18757498
[TBL] [Abstract][Full Text] [Related]
14. Small-cell lung carcinoma: inhibition of proliferation by vasoactive intestinal peptide and helodermin and enhancement of inhibition by anti-bombesin antibody.
Maruno K; Said SI
Life Sci; 1993; 52(24):PL267-71. PubMed ID: 8389407
[TBL] [Abstract][Full Text] [Related]
15. Peptide hormone production in small cell lung carcinomas with particular reference to gastrin-releasing peptide.
Yamaguchi K; Abe K; Adachi I; Otsubo K; Nagasaki K; Suzuki M; Maruno K; Asanuma F; Tsuchihashi T; Miyake Y
Jpn J Clin Oncol; 1986 Sep; 16(3):235-41. PubMed ID: 3022032
[TBL] [Abstract][Full Text] [Related]
16. Human H9 cells proliferation is differently controlled by vasoactive intestinal peptide or peptide histidine methionine: implication of a GTP-insensitive form of VPAC1 receptor.
Goursaud S; Pineau N; Becq-Giraudon L; Gressens P; Muller JM; Janet T
J Neuroimmunol; 2005 Jan; 158(1-2):94-105. PubMed ID: 15589042
[TBL] [Abstract][Full Text] [Related]
17. Cyclic AMP formation in chicken brain: effect of vasoactive intestinal peptide, peptide histidine-isoleucine (PHI), and some PHI-related peptides.
Dejda A; Matczak I; Wiktorowska-Owczarek A; Nowak JZ
Pol J Pharmacol; 2003; 55(5):747-51. PubMed ID: 14704471
[TBL] [Abstract][Full Text] [Related]
18. Vasoactive intestinal peptide control of cyclic adenosine 3':5'-monophosphate levels in seven human colorectal adenocarcinoma cell lines in culture.
Laburthe M; Rousset M; Chevalier G; Boissard C; Dupont C; Zweibaum A; Rosselin G
Cancer Res; 1980 Jul; 40(7):2529-33. PubMed ID: 6248206
[TBL] [Abstract][Full Text] [Related]
19. Porcine peptide having N-terminal histidine and C-terminal isoleucine amide (PHI): vasoactive intestinal peptide (VIP) and secretin-like effects in different tissues from the rat.
Bataille D; Gespach C; Laburthe M; Amiranoff B; Tatemoto K; Vauclin N; Mutt V; Rosselin G
FEBS Lett; 1980 Jun; 114(2):240-2. PubMed ID: 6248367
[No Abstract] [Full Text] [Related]
20. Effect of vasoactive intestinal peptide, bombesin and substance P on fluid secretion by isolated rat pancreatic ducts.
Ashton N; Argent BE; Green R
J Physiol; 1990 Aug; 427():471-82. PubMed ID: 1698981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
